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SUMMARY
Wehavecreatedamousegeneticmodel thatmimicsa
humanmutationofShank3 thatdeletes theC terminus
and is associated with autism. Expressed as a single
copy [Shank3(+/DC) mice], Shank3DC protein inter-
acts with the wild-type (WT) gene product and results
in >90% reduction of Shank3 at synapses. This ‘‘gain-
of-function’’ phenotype is linked to increasedpolyubi-
quitination of WT Shank3 and its redistribution into
proteasomes. Similarly, the NR1 subunit of the
NMDAreceptor is reducedatsynapseswith increased
polyubiquitination. Assays of postsynaptic density
proteins, spine morphology, and synapse number
are unchanged in Shank3(+/DC) mice, but the ampli-
tude of NMDAR responses is reduced together with
reduced NMDAR-dependent LTP and LTD. Recipro-
cally, mGluR-dependent LTD is markedly enhanced.
Shank3(+/DC) mice show behavioral deficits sugges-
tive of autism and reduced NMDA receptor function.
These studies reveal a mechanism distinct from hap-
loinsufficiency by which mutations of Shank3 can
evoke an autism-like disorder.
INTRODUCTION
Autism represents a broad spectrum of behavioral and cognitive
disorders characterized by early onset deficit of language devel-
opment and social interactions, accompanied by repetitive
behaviors. Most cases of autism spectrum disorders (ASD) are
sporadic and cannot yet be linked tomutations of specific genes.
Nevertheless, a significant fractionofASD is causedbydenovoor
rare mutations (Geschwind, 2008). One of the most commonly
associated genetic conditions is fragile X mental retardation
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Mouse models that delete the Fmr1 gene show changes in
synaptic plasticity; especially enhanced mGluR evoked long-
term depression, which has been linked to cognitive deficits
(Huber et al., 2002). Another ASD-linked mutation involves the
Shank3 gene, also called ProSAP1/CortBP1. Shank3 is located
on chromosome 22q13.3 in humans and was first implicated in
ASD associated with the 22q13.3 microdeletion syndrome (also
known as the Phelen-McDermid Syndrome) characterized by
dysmorphic facial features, delayed expressive speech, and
autistic behavior (Nesslinger et al., 1994). Subsequent genetic
analysisof patientswith chromosome22q13.3deletion syndrome
revealed a balanced translocation of chromosomes 12 and 22
causing a disruption of Shank3 gene at exon 21, implicating the
haploinsufficiency of Shank3 gene as a causal mechanism
(Bonaglia et al., 2001). More recently, heterozygous mutations in
Shank3 gene have been shown to cause ASD in a gene-dosage-
dependent manner (Durand et al., 2007; Moessner et al., 2007).
ASD cases with Shank3 mutations range from severe cases of
autistic disorder to milder variants with Asperger syndrome
(Durand et al., 2007). Genome-wide association studies confirm
the link between Shank3 mutations and ASD (Marshall et al.,
2008; Sebat et al., 2007). Additionally, a Shank3 mutation is re-
ported in association with schizophrenia (Gauthier et al., 2010).
Shank proteins are products of three related genes, Shank1–
Shank3, and are expressed as a number of spliced variants.
Shank proteins include 5–6 N-terminal ankyrin repeats followed
by a well-conserved SH3 (Src homology 3) domain, a PDZ
(PSD95/Discs large/zona-occludens-1) domain, a proline-rich
domain, and a C-terminal SAM (sterile alpha motif) domain.
Homer proteins bind Shank to create a polymeric network
structure that is dependent on Homer tetramerization, as well
as physical interactions between Shank proteins (Hayashi
et al., 2009). Human genetic studies point toward a possible
role of Shank3-Homer interaction in ASD. The balanced translo-
cation of chromosomes 12 and 22 causes a disruption of exon
C
A21, which encodes the Homer-binding site (Bonaglia et al.,
2001). A second instance involves two siblings heterozygous
for a guanine insertion in exon 21, creating a frameshift and
a truncated Shank3 protein lacking the Homer-binding site
(Durand et al., 2007). Point mutations elsewhere in Shank3, for
instance within the ankyrin repeats, are also associated with
ASD but are typically less severe than mutations with loss of
the Homer-binding domain (Durand et al., 2007).
To examine the importance of Shank3-Homer interaction in
the pathogenesis of ASD, we generated a mouse model of
Shank3 that deletes the Homer-binding domain at the
C terminus (DC), thus mimicking the reported mutation in ASD
patients (Durand et al., 2007). Here we report that the heterozy-
gous DC Shank3 mutation results in a striking downregulation of
wild-type (WT) Shank3. This downregulation of Shank3 is not
consistent with a simple gene-dosage model because Shank3
at excitatory synapses is reduced >90%. Instead, we find an
increase in WT Shank3 that is polyubiquitinated and relocalized
to proteasomes. This effect appears highly specific to Shank3
given that Shank3DC does not result in downregulation of
Shank1, Shank2, GKAP, AMPA type glutamate receptors, or
most other synaptic proteins. The notable exception is the NR1
subunit of the NMDA receptor (NMDAR), which is downregulated
at synapses in association with increased polyubiquitination.
Assays of synaptic morphology and synapse number do not
reveal differences between adult WT and Shank3(DC) mice.
However, electrophysiological studies confirm a reduction of
NMDAR responses in cortical and hippocampal neurons and
reduced NMDAR-dependent long-term potentiation (LTP) and
long-term depression (LTD). Moreover, the amplitude of
mGluR-LTD is increased in the hippocampi of Shank3(+/DC)
mice. Studies of Shank3(DC) mice in behavioral assays reveal
deficits of social interaction, consistent with ASD. Additionally,
Shank3(+/DC) mice show enhanced locomotor responses to
amphetamine and the NMDA antagonist MK-801, consistent
with the reduction of NMDAR function and similar to ‘‘schizo-
phrenia-like’’ symptoms reported inmousemodels with reduced
NR1 expression (Mohn et al., 1999). Our studies reveal a molec-
ular pathway that may underlie neurodevelopmental disorders
linked to human mutations of Shank3.
RESULTS
Generation of the DC Shank3 Mouse
To determine how Homer affects Shank3 expression in vivo, we
examined Homer-triple knockout (HTKO)mice for Shank3 levels.
Thesemice lack all Homer (1, 2, 3, and 1a) isoforms.We found an
80% reduction in Shank3 in cortical lysates using three indepen-
dent Shank3 antibodies (Figures S1A and S1B available online).
Shank1 and 2 isoforms, which also bind Homer, were reduced
50%. Similarly, cortical cultures from the HTKO mice showed
80% reduction in Shank3 as measured by immunohistochem-
istry (Figures S1C–S1E). Single Homer1 KO mice had 40%
reduction in Shank3 (Figure S1F). We were able to rescue the
reduction in Shank3 levels in the HTKO cultures by transiently
expressing full-length Homer1c isoform (Figure S1G), but not
point mutants of Homer1c (W24A and G89N) that do not bind
Shank3 (Beneken et al., 2000), suggesting that the physical
RE
TRassociation of Homer with Shank3 is necessary to maintain
Shank3 levels. We found no evidence of changes in Shank3
mRNA in the HTKO brains (Figure S1H). These data support
the notion that Homer stabilizes Shank3 protein in vivo.
Given the reduction of Shank3 in the Homer TKO and the
importance of Shank3 in ASD, we generated a mouse that
affords conditional deletion of exon 21 of Shank3 (Figure S1I).
Excision of exon 21 creates a frameshift such that the resulting
Shank3 protein (termed ShankDC) is predicted to lack the entire
C-terminal portion of Shank3, including the Homer-binding site
in the proline-rich domain and the SAM domain (Figure S1K).
We confirmed excision of exon 21 in a cross with a mouse
expressing actin-Cre (Figure S1J) and evaluated expression of
Shank3 proteins using N- and C-terminal targeted Shank3 anti-
bodies reacted with cortical lysates from WT Shank3(+/+),
Shank3(+/DC), and Shank3(DC/DC) mice (Figure 1A). Both the
C-terminal antibodies (JH3025 and H160) reacted with two
prominent bands (190 and 120 kDa) that are absent in
Shank3(DC/DC), indicating that they specifically detect Shank3.
The N-terminal Shank3 antibody reacted with a single band
that is the same apparent molecular weight (MW) as the largest
band detected by the C-terminal antibody and is absent in
Shank3(DC/DC). Additionally the N-terminal antibody (Ab) re-
acted with an 90 kDa band that is present in Shank(DC/DC)
and Shank(+/DC) but absent in Shank3(+/+) (Figure 1A). These
studies confirm the specificity of antibodies and demonstrate
expression of mutant Shank3DC protein in brain.CT
EDGain-of-Function Reduction of WT Shank3
in the Shank3(+/DC) Mouse
Because Shank3 mutations in humans are associated with ASD
in a heterozygote genotype (Durand et al., 2007), we decided to
analyze the Shank3(+/DC)mouse. Shank3(+/DC)micewere born
with expected Mendelian frequency and appeared healthy and
of normal size through development and into adulthood.
Biochemical analysis, with three independent Shank3-specific
antibodies (JH3025, H160, and N-term), of the Shank3(+/DC)
cortical lysates of 8-week-old mice revealed a 70%–80% reduc-
tion in Shank3 protein levels (Figures 1B and 1C). We also
assessed Shank3 levels in days in vitro (DIV) 14–21 cortical
cultures made from Shank3(+/DC) mice and found a similar
75% reduction in Shank3 with no change in PSD-95 or Vglut1
(Figures 1D and 1E). The measured loss of Shank3 in the
Shank3(+/DC) cultures increased to 90% when we assayed in
synaptic fractions (Figure 1F), suggesting that Shank3 at the
synapse is preferentially downregulated. We did not observe
changes in other Shank isoforms (Shank1 and 2) or other scaf-
folding molecules GKAP, PSD-95, Homer, and Neuroligin-3
in cortical lysates (Figures 1B and 1C). However, we did
detect 50% reduction in NMDAR subunit NR1 levels in the
Shank3(+/DC) cortex without significant changes in NR2A,
NR2B, AMPA (GluR1), or mGluR5 (Figures 1B and 1C). Shank3
mRNA in Shank3(+/DC) brains was 90% that of Shank3(+/+)
(Figure 1G), likely representing compensation from theWT allele.
This indicates that the downregulation of Shank3 protein in
Shank3(+/DC) is not due to a commensurate reduction of
Shank3 mRNA.Cell 145, 758–772, May 27, 2011 ª2011 Elsevier Inc. 759
Figure 1. Gain-of-Function Reduction of Shank3 in the Shank3(+/DC) Mice
(A) Representative immunoblots from cortical lysates blotted with JH3025 C-terminal antibody (Ab), H-160 C-terminal Ab, and an N-terminal Ab against Shank3.
Multiple bands represent spliced Shank3 variants. Lysates from DC/DC mouse served as negative control. JH3025 gives a nonspecific band 45 kDa. Actin is
used as loading control. See also Figure S1J.
(B) Representative immunoblots from cortical lysates of three independent littermate pairs of WT and Shank3(+/DC) mice aged P60.
(C) Quantification of protein levels in (A). n = 3 littermate pairs; **p < 0.01; *p < 0.05.
760 Cell 145, 758–772, May 27, 2011 ª2011 Elsevier Inc.
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AIncreased In Vivo Polyubiquitination of WT Shank3
in the Shank3(+/DC) Mouse
We examined the notion that reduced expression of WT Shank3
in the Shank3(+/DC) mouse might be linked to enhanced ubiqui-
tination, as Shank proteins have been reported to be ubiquiti-
nated (Ehlers, 2003). Wild-type Shank3 was immunoprecipitated
from cortical lysates with C-terminal Ab and assayed for polyu-
biquitination using the FK1 Ab (Figure 2A). A 2-fold increase in
polyubiquitinated Shank3 was evident in the Shank3(+/DC)
mouse (Figure 2B). Because polyubiquitination can be a signal
for proteasomal degradation, we examined colocalization of
WT Shank3 with a proteasomal marker Rpt6 in cortical cultures
and detected a 2.5-fold increase in Shank3 puncta colocalizing
with Rpt6 in cultures from the Shank3(+/DC) mice (Figures 2C
and 2D). These findings suggest that the increased polyubiquiti-
nation of Shank3 results in enhanced proteasomal degradation
in Shank3(+/DC) mice. We found no change in total Rpt6 levels
in +/DC cortical lysates (Figures 2E and 2F), indicating that there
was no global upregulation of the proteasome.
Shank3DC protein is expressed in brain of Shank3(+/DC) mice
(Figure 2G, Input) and coimmunoprecipitates with WT Shank3
in vivo (Figure 2G). Shank3DC also coimmunoprecipitated
(co-IPed) with WT Shank3 when these proteins were coex-
pressed in HEK293 cells (data not shown), indicating that
Shank3 proteins can physically associate independently of their
C-terminal SAM domain. The physical association of Shank3DC
with WT Shank3 may be important for increased polyubiquitina-
tion of Shank3, although this issuewill require further analysis. To
confirm that Shank3DC is causal for enhanced degradation of
Shank3, we expressed Shank3DC transgene in WT cortical
cultures and found a 65% reduction in WT Shank3 (Figures 2H
and 2I) and an 80% reduction in synaptic Shank3 (Figure 2J)
with no reduction in Vglut1. We examined the possibility that
Shank3DC is ubiquitinated using the N-terminal Shank3 Ab for
immunoprecipitation but failed to detect ubiquitinated
Shank3DC (data not shown).
We considered a model in which the disruption of Homer
binding to Shank3 might result in its enhanced polyubiquitina-
tion. To negate possible effects of Shank3DC protein, we exam-
ined cortical lysates from Homer TKO and found a 2-fold
increase in polyubiquitinated Shank3 (Figures S2A and S2B).
Similarly, we found a 2-fold increase in Shank3-Rpt6 colocaliza-
tion in cortical cultures from the Homer TKO (Figures S2C and
S2D). We also looked at the role of the activity-dependent
dominant-negative Homer isoform, Homer1a. Overexpression
of Homer1a in cortical cultures resulted in 50% reduction of
Shank3 (Figures S2E and S2F), whereas the Homer1a KOmouse
cortex had about a 2.5-fold increase in Shank3 (Figures S2G and
S2H) and a concomitant 2-fold reduction in Shank3 polyubiquiti-
nation (Figures S2I–S2J). These findings suggest that interrup-
RE
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were used as control for Shank3 Ab. Scale bar, 10 mm.
(E) Quantification of puncta density (see Experimental Procedures) from (D). 70
pendent littermate pairs; **p < 0.01.
(F) Quantification of synaptic protein per mm from (D). Synaptic protein was defined
7000–9000 mm of dendrites was examined from culture sets from three indepen
(G) Quantification of brain Shank3 mRNA levels from real-time PCR analysis. n =
All quantitative data are shown as means ± SEM. All p values are derived from ation of Homer binding is sufficient to evoke enhanced proteaso-
mal degradation of Shank3.
NR1 Polyubiquitination Is Increased
in the Shank3(+/DC) Mice
Our initial observation of NR1 reduction in cortical lysates from
Shank3(+/DC) mice was verified in cortical synaptoneurosomal
(P2) fractions, which showed 70% reduction in NR1 with no
significant changes in NR2A, GluR1, GluR2, or mGluR5 (Figures
3A and 3B). Similarly, we found50% reduction in both total and
surface NR1 using cortical cultures from Shank3(+/DC) mice
(Figures 3C–3E). This decrease in NR1 levels could not be
explained by a transcription defect because the NR1 mRNA
levels were unaltered in the Shank3(+/DC) mice compared to
WT (Figure 3F). NR1 is reported to undergo ubiquitination (Kato
et al., 2005); therefore we assessed whether polyubiquitination
of NR1 could underlie the NR1 reduction in the Shank3(+/DC)
mice. Cortical lysates immunoprecipitated with NR1 and
assayed for polyubiquitination using the FK1antibody (Figure 3G)
revealed an 3-fold increase in polyubiquitinated NR1 in
Shank3(+/DC) lysates (Figure 3H). Similarly, NR1 expression in
HTKO cortex was reduced 50% (Figures S3A and S3B) with
increased polyubiquitination (Figures S3C and S3D).
Reduction of NMDAR-Dependent Synaptic Responses
in Cortexes of Shank3(+/DC) Mice, without Changes
in Synapse Number or Morphology
As NR1 is an obligatory subunit of functional NMDAR, we pre-
dicted that a change inNR1 levelswouldalterNMDAR-dependent
synaptic responses. Using acute cortical slices from frontal
cortexes of 3- to 4-week-old mice, we monitored the amplitude
of evoked responses in layer 2/3 cortical neurons following stimu-
lation of presynaptic fibers in layer 4, using conditions that sepa-
rately revealAMPA-andNMDAR-dependent responses. The ratio
of the NMDA/AMPA-dependent responses in Shank3(+/DC)
cortex was reduced compared to the WT mice (0.38 ± 0.07 in
the Shank3(+/DC); 0.70 ± 0.06 in littermate WT; p < 0.005) (Fig-
ure 4A, Figures S4A and S4B). The voltage dependence of the
evoked AMPA current was similarly linear in WT and Shank3(+/
DC) (Figure S5A). The AMPAR-mediated miniature excitatory
postsynaptic current (EPSC) amplitude and frequency were unal-
tered (WT 15.2 ± 1.2 pA, 10.3 ± 1.7 Hz; Shank3(+/DC) 15.4 ±
0.9 pA, 8.6 ± 0.9 Hz) (Figure 4B and Table S1). These results are
consistent with biochemical data and suggest a selective reduc-
tion of synaptic NMDAR responses.
Shank3 has been postulated to be a scaffolding molecule with
putative roles in PSD maintenance, spine morphogenesis, and
NMDAR and AMPAR function (Roussignol et al., 2005). Accord-
ingly, we assessed whether changes in synaptic function might
be coupled to cyto-architectural changes. We prepared electron
CT
EDith Shank3 (JH3025), Psd-95, and Vglut1. Cortical cultures from DC/DC mice
00–11,000 mm of dendrites was examined from culture sets from three inde-
as an area overlap between Shank3 or Psd-95 and the synaptic marker Vglut1.
dent littermate pairs; **p < 0.01.
3 independent littermate pairs; difference nonsignificant.
Student’s t test. See also Figure S1.
Cell 145, 758–772, May 27, 2011 ª2011 Elsevier Inc. 761
Figure 2. Increased Polyubiquitination of Shank3 Is Mediated by DC
(A) Coimmunoprecipitation assay from cortical lysates to assess in vivo polyubiquitination of Shank3 in the +/DC mouse. Polyubiquitinated Shank3 ran at
250 kDa because of added polyubiquitin. Lysates from Shank3(DC/DC) were used as negative control.
(B) Quantification of relative Shank3 polyubiquitination from (A) (normalized toWT). y axis is FK1 polyubiquitin signal relative to immunoprecipitated Shank3. n = 3
independent littermate pairs; *p < 0.05.
(C) Representative confocal images from DIV 14–21 cortical cultures fromWT and Shank3(+/DC) colabeled with Shank3 and the proteasomal marker Rpt6. Scale
bar, 5 mm.
(D) Quantification of colocalization (area overlap per mm of dendrite) between Shank3 and Rpt6 from (C). 5000–7000 mm of dendrites was examined from culture
sets from three independent littermate pairs; **p < 0.01.
762 Cell 145, 758–772, May 27, 2011 ª2011 Elsevier Inc.
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Amicroscopy (EM) images of layer 5 somatosensory cortexes of
8-week-old mice and found no change in PSD length or thick-
ness in Shank3(+/DC) mice (Figures 4C–4E). We also examined
spine density by labeling neurons in fixed tissue with biolistic-
DiI (Figure 4F) and performed automated counting and found
no change in spine density (Figure 4G) or spine volume (Figures
4H–4J and Figure S4D) in 8-week-old Shank3(+/DC) mice.
Similarly, synapsin staining of DIV 14–21 cortical neurons re-
vealed identical puncta density in Shank3(+/DC) and WT mice
(Figures S5B and S5C). These data indicate that spine and
synapse formation are not altered in representative regions of
adolescent Shank3(+/DC) brain and cultured neurons and are
consistent with preservation of spontaneous miniature excit-
atory postsynaptic current (mEPSC) frequency and amplitude
in Shank3(+/DC) brain. Accordingly, changes in NMDAR function
are likely due to reduced expression rather than spine dysmor-
phogenesis or deficits of synapse formation.
NMDAR and Group I mGluR Synaptic Plasticity
Are Altered in Hippocampi of Shank3(+/DC) Mice
We used acute hippocampal slices to assess whether NR1
reduction in the Shank3(+/DC) mice alters aspects of synaptic
plasticity. We first examined the efficacy of Schaffer collateral-
CA1 synapses by monitoring the evoked field excitatory post-
synaptic potential (fEPSP) following paired pulses as an indicator
of presynaptic function. This responsewas not different between
WT and Shank3(+/DC) mice (Figure S5D). Similarly, analysis of
the amplitude of the presynaptic fiber volley relative to both the
initial slope of the fEPSP (Figure S5E) and the peak of the
population spike (Figure S5F) revealed no change in either rela-
tionship. The former indicates that basal synaptic efficacy was
unaltered, and the combination of both measures suggests
that the intrinsic conductances underlying spike generation are
not altered in Shank3(+/DC) mice.
LTP was induced by four trains of high-frequency stimulation
with an inter-train interval of 5 min. In WT, fEPSP increased to
170.8% ± 8.3% of baseline immediately after stimulation
(t = 60 min) and sustained at the level of 158.4% ± 13.8%
of baseline at t = 180 min (Figure 5A). In Shank3(+/DC) mice
the magnitude of LTP induction was significantly reduced
(143.1% ± 5.6% of baseline at t = 60 min after stimulation) and
decayed more rapidly than in WT mice (115.1% ± 4.9% of base-
line at t = 180 min, p < 0.005, Student’s t test). NMDAR-depen-
dent LTD of Schaffer collateral-CA1 synapses was also reduced
in Shank3(+/DC) mice. LTD was evoked using low-frequency
synaptic stimulation (LFS) and resulted in a stable reduction of
synaptic strength to 82.0% ± 3.3% of baseline at t = 30 min
(Figure 5B). In Shank3(+/DC)mice, the initial synaptic depressionRE
TR(E) Representative Immunoblot from total cortical lysates showing total Rpt6 leve
(F) Quantification of protein levels in (E). n = 3 independent littermate pairs; p > 0
(G) Coimmunoprecipitation assay from cortical lysates showing that DC binds ful
and the N-terminal Shank3 Ab (N). Protein samples in the input were immuno
N-terminal Shank3 Ab that recognized the DC band in the +/DC but not the WT
(H) Representative confocal images from DIV 12–14 WT cortical cultures 24 hr a
(I) Quantification of puncta density from (H). 5000–7000 mm of dendrites was exa
(J) Quantification of synaptic protein per mm from (H). Synaptic protein was define
was examined from three independent culture sets; **p < 0.01.
All quantitative data are shown as means ± SEM. All p values are derived from awas not different fromWT but beginning after 20 min returned to
near prestimulus baseline (95.7% ± 2.9% of baseline at
t = 30 min, p < 0.05, Student’s t test). These findings are consis-
tent with a reduction of postsynaptic NMDAR function.
Next we examined mGluR-dependent chemical LTD in slices
from 3- to 4-week-old Shank3(+/DC) mice. LTD of Schaffer
collateral-CA1 synapses was induced by the group I mGluR
agonist DHPG (100 mM) for 5 min. In WT slices, bath-applied
DHPG resulted in a stable reduction of synaptic strength
(69.1% ± 5.0% of baseline at t = 90 min) (Figure 5C). In
Shank3(+/DC) mice, mGluR-LTD by DHPG was increased
(56.9% ± 3.8% of baseline at t = 90 min, p < 0.05, Student’s t
test). Similarly, LTD produced by paired-pulse low-frequency
stimulation (PP-LFS: 1 Hz for 20 min) was increased in the
Shank3(+/DC) mice (88.7% ± 1.9% of baseline at t = 40 min in
WT mice compared to 74.3% ± 4.6% of the baseline at
t = 40 min in Shank3(+/DC) mice) (Figure 5D). The increase of
mGluR-LTD in the Shank3(+/DC) is similar to the increase in
Fmr1 KO mice. However, unlike the fragile X model, the
mGluR-LTD increase in the Shank3(+/DC) mice was completely
inhibited by the protein synthesis inhibitor cycloheximide
(Figure 5E), indicating that the mechanism affecting mGluR-
LTD may be different in these two models.
Shank3(+/DC) Mice Display Selective Deficits
of Social Interactions
We first examined cognitive function, as a baseline for studies of
social interactions. Long-term spatial memory tested in a classic
version of the Morris water maze (Figures S6A and S6B) as well
as short-term spatial recognition and spatial working memory
(Table S2) were not different between Shank3(+/DC) and WT
mice. In addition, a classical fear-conditioning paradigm showed
that context and cue-related fear memory and extinction in
Shank3(+/DC) mice were similar to WT (Figures S6C and S6D).
Shank3(+/DC) mice also showed normal anxiety levels (Table
S2) and learning of motor skills (Figure S6E). These data indicate
that Shank3(+/DC) mice exhibit preserved learning and memory
functions.
A separate group of Shank3(+/DC) mice was tested in a set of
social tasks in which accessibility and familiarity of social stimuli
were modulated in a controlled fashion. First, we analyzed recip-
rocal social interactions in a habituation-dishabituation para-
digm that provides a measure of hippocampus- and amyg-
dala-dependent social memory and has been used in mouse
models associated with ASD (Ferguson et al., 2002). As ex-
pected, WT mice showed a decrease in duration of social inves-
tigation during repeated presentations of the same stimulus
mouse followed by a reactivation of investigation when a novel
CT
EDls in WT and Shank3(+/DC) mice.
.05.
l-length Shank3 in vivo. The input lysates were blotted with JH3025 Shank3 (C)
precipitated with Shank3 (H-160) Ab and analyzed for DC binding using the
lane. NS = nonspecific bands.
fter Myc-DC transient transfection. Scale bar, 5 mm.
mined from three independent culture sets; **p < 0.01.
d as an area overlap between Shank3 and Vglut1. 5000–7000 mm of dendrites
Student’s t test. See also Figure S2.
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Figure 3. NR1 Reduction in the Shank3(+/DC) Mice Is due to Enhanced Polyubiquitination
(A) Representative immunoblots from cortical P2 (synaptoneurosomal) fractions from WT and Shank3(+/DC) mice aged P42.
(B) Quantification of protein levels in (A). n = 3 independent littermate pairs; **p < 0.01; *p < 0.05.
(C) Representative immunoblots from DIV 14–21 cortical cultures from two independent WT and Shank3(+/DC) sets. Surface samples are from biotinylated
lysates immunoprecipitated with avidin.
(D) Quantification of surface protein levels in (C). n = cultures from three independent littermate pairs; *p < 0.05.
(E) Quantification of total protein levels in (C). n = cultures from three independent littermate pairs; *p < 0.05.
(F) Quantification of brain NR1 mRNA levels from real-time PCR analysis. n = 3 littermate pairs; difference is nonsignificant.
(G) Coimmunoprecipitation assay from cortical lysates to assess in vivo polyubiquitination of NR1 in the Shank3(+/DC) mice.
(H) Quantification of in vivo NR1 polyubiquitination from (G). y axis is FK1 polyubiquitin signal relative to immunoprecipitated NR1. n = 3 independent littermate
pairs; *p < 0.05.
All quantitative data are shown as means ± SEM. All p values are derived from a Student’s t test. See also Figure S3.
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Figure 4. Reduction of NMDAR-Mediated Synaptic Responses in Cortexes of Shank3(+/DC) Mice, without Changes in Spine Number or
Morphology
(A) Raw (gray) and averaged (black) traces from a series of 20 consecutive evoked EPSCs in cortical slices. The NMDA/AMPA ratio is diminished in Shank3(+/DC)
neurons (n = 15, 5 mice) compared with WT (n = 9, 4 mice). **p < 0.005 (scale bars, 50 pA/50 ms).
(B) Representative whole-cell recording traces and cumulative probability (CP) distribution of AMPA mEPSC amplitude and frequency from all events in WT (n =
22) and Shank3(+/DC) (n = 23) neurons. Differences are nonsignificant for both amplitude and frequency. Inset: bar graphs represent the mean amplitude or
frequency of each population ± SEM (scale bars, 50 pA/0.1 s).
(C) Exemplar electron micrographs of spine synapses in layer V of the somatosensory cortexes from WT and Shank3(+/DC) mice showing the presence of the
postsynaptic density (arrows), synaptic vesicles (arrowheads), and dendritic spines (asterisks). The following quantifications in (D) and (E) are from spine synapses
in layer V of the somatosensory cortex. scale bar = 100 nm.
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stimulusmousewas presented (Figure 6A). Approximately half of
the WT mice showed a short single bout of aggression per trial
(Figure 6D, Figures S6F and S6I). The presence of these aggres-
sion episodes did not disrupt normal habituation-dishabituation
curves in WT mice (Figures 6B and 6C). By contrast,
Shank3(+/DC) mice displayed significantly lower levels of social
investigation (Figure 6A) that were modulated by the presence of
aggressive episodes (Figures 6B and 6C). Shank3(+/DC) mice
with aggressive behaviors showed significantly less social inves-
tigation as compared to WT (Figure 6C), whereas Shank3(+/DC)
mice that did not demonstrate aggression were not different
from controls (Figure 6B).
A similar interference between aggressive behaviors and
social investigation was observed in a separate cohort of
Shank3(+/DC) mice exposed to stimulus mice of different strain
backgrounds (Figures S6G and S6I). Multiple tests for odor
recognition and discrimination (Figures S6K and S6L) indicated
preserved olfactory processing in Shank3(+/DC) mice. A sharp
increase in aggression toward a novel stimulus mouse observed
in Shank3(+/DC) mice (Figure 6D, Figure S6F) suggested
preserved social recognition memory as well. This was
confirmed by additional testing in a situation where aggression
toward a stimulus mouse is prevented by placing the stimulus
mouse under an enclosure. In this situation, Shank3(+/DC)
mice showed levels of social investigation comparable to those
in WT (Figure 6E). These data indicate that Shank3(+/DC) mice
have preserved social recognition memory but display aberrant
social interactions with aggressive behaviors.
To test whether Shank3(+/DC) mice are more aggressive in
general, we employed two commonly used protocols: neutral
arena and resident-intruder tests. As expected, aggressive
behaviors significantly intensified when tested in the resident-
intruder test (Figure 6F, Figure S4J); however there were no
genotype-related differences in any of the test conditions. These
data indicate that increased aggressive behaviors observed in
Shank3(+/DC) mice during the dishabituation stage of the social
recognition task were not a result of general augmentation of
aggression.
To analyze possible changes in social motivation of
Shank3(+/DC) mice, we tested approach behaviors to enclosed
male or female conspecifics. Shank3(+/DC) mice spent more
time investigating an enclosed male stimulus mouse than WT
mice (Figures 6G and 6I). This difference remained significant
after repeated testing (Figure 6J), indicating that the increase in
social investigation of an enclosed male mouse was not a result
of generalized exploratory activation of Shank3(+/DC) mice. The
ET
RA(D) The PSD length is not significantly different in the WT and the +/DC mice. n =
(E) The PSD thickness is not significantly different in the WT and the +/DC mice.
(F) Representative DiI-labeled images of layer V pyramidal neurons of the som
reconstructions depicting faithful labeling of spines by the filament module in Im
(G) Quantification of spine density (spines per mm) in layer V, layer II/III pyramidal n
Shank3(+/DC) mice. n = 9–29 cells from three independent littermate pairs. Diffe
(H) Quantification of spine volume in layer V pyramidal neurons of the somatose
independent littermate pairs. p > 0.05.
(I) Quantification of spine volume in layer II/III pyramidal neurons of the somatose
independent littermate pairs. p > 0.05.
(J) Quantification of spine volume in CA1 pyramidal neurons from WT and Shank3
All quantitative data are shown as means ± SEM. All p values are derived from a
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Rsame mice were then tested with a sexually receptive enclosed
female. Total duration of social investigation was similar between
Shank3(+/DC) and WT mice (Figures 6H and 6K), but measures
that specifically reflect an approach behavior showed signifi-
cant genotype-related differences. The approach latency in
Shank3(+/DC) was significantly longer than WT (Figure 6L). To
confirm this finding, an additional cohort of sexually naive male
mice was tested during reciprocal interactions with females.
Because in this situation the approach behavior can be affected
by a free-roaming female mouse, we recorded ultrasonic calls
that males emit in the presence of females. Latencies to the first
ultrasound call emitted by Shank3(+/DC) mice were significantly
longer than WT (Figure 6M). Thus, these data indicate that
Shank3(+/DC) mice have significant differences from WT in
social approach behavior, communications, and social recip-
rocal interactions with male and/or female conspecifics.
Shank3(+/DC)Mice Display Behavioral Traits Consistent
with Reduced NMDAR Function
Schizophrenia-related phenotypes are reported in mouse
models with reduced NMDAR function (Mohn et al., 1999).
Accordingly, we extended our battery of behavioral tasks to
include schizophrenia-related phenotypes in Shank3(+/DC)
mice. We first utilized prepulse inhibition of startle reaction
(PPI). In this paradigm, a brief, low-intensity acoustic stimulus
(the prepulse) inhibits the startle reflex caused by a loud stimulus.
Shank3(+/DC) mice showed significantly lower amplitudes and
longer latencies of startle response than WT (Figure 7A; Figures
S7A–S7D). The levels of prepulse inhibition were not different
between genotypes as assessed by ANOVA (Figure 7B).
However, the prepulse inhibition inWTwas negatively correlated
with startle amplitude (Figures 7C–7D; Figure S5E; Tables S3)
resulting in an underestimation of prepulse inhibition in the
control group due to their higher levels of startle (Figure 7A). To
correct for these differences we employed an analysis of covari-
ance (ANCOVA) with the amplitude of startle reaction as a contin-
uous predictor variable. This analysis revealed a significant
effect of Genotype and Genotype 3 Trial interaction due to
differences between Shank3(+/DC) and WT in the most chal-
lenging type of trials, which consisted of a combination of the
highest level of startle stimulus and the lowest level of prepulse
(Figure 7E).
We also tested sensitivity to psychostimulants; a preclinical
correlate of positive symptoms used extensively in animal
models of schizophrenia (Powell andMiyakawa, 2006). Systemic
injection of dizocilpine (MK-801), a noncompetitive NMDAR
TE
D88 for WT; n = 146 for Shank3(+/DC); p > 0.05.
n = 68 for WT; n = 131 for Shank3(+/DC); p > 0.05.
atosensory cortexes from WT and Shank3(+/DC) mice. To the right are 3D
aris. Scale bar, 10 mm.
eurons of the somatosensory cortex, and CA1 pyramidal neurons fromWT and
rence is nonsignificant.
nsory cortexes from WT and Shank3(+/DC) mice. n = 671 spines from three
nsory cortexes from WT and Shank3(+/DC) mice. n = 2805 spines from three
(+/DC) mice. n = 853 spines from three independent littermate pairs. p > 0.05.
Student’s t test. See also Figure S4.
Figure 5. NMDAR-Dependent LTP and LTD and Group I mGluR-LTD Are Altered in Hippocampal Slices Derived from Shank3(+/DC) Mice
(A) HFS-induced LTP is significantly more reduced in Shank3(+/DC) mice than in littermate WT. p < 0.005 (scale bars, 1 mV/10 ms).
(B) NMDAR-dependent LTD of Schaffer collateral-CA1 synapses is reduced in Shank3(+/DC) mice. p < 0.05 (scale bars, 1 mV/10 ms).
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antagonist, dose-dependently increased locomotor activity in
both genotypes (Figure 7F) However, the levels of motor activa-
tion were significantly higher in Shank3(+/DC) compared to WT
(Figure 7G). Similarly, amphetamine, a known psychostimulant
that exerts its action through release of dopamine, resulted in
a significantly stronger activation in Shank3(+/DC) compared
to WT (Figures 7H and 7I). By contrast, Shank(+/DC) mice did
not show novelty-induced hyperactivity (Figures S7J and S7H),
indicating that the increased motor activity induced by MK-801
and amphetamine is specific to these agents.
DISCUSSION
The present study supports a ‘‘gain-of-function’’ mechanism for
synaptic and behavioral dysfunction in a mouse model designed
to mimic human mutations of Shank3 associated with ASD
(Durand et al., 2007). In combination with observations from
Homer KO mice, we propose a model in which perturbations
that reduce the stability of the Homer-Shank3 protein complex
result in increased ubiquitination of Shank3 and reduced expres-
sion at the synapse. Changes of NR1 expression and ubiquitina-
tion are coupled to changes in Shank3. Determinants of the
stability of the Homer-Shank protein complex have been re-
ported in biochemical and crystallographic studies (Hayashi
et al., 2009) and are consistent with our findings. Our model is
also consistent with a report that Shank proteins undergo ubiq-
uitination in physiological adaptations to neuronal activity
(Ehlers, 2003). Data regarding effects of reduced expression of
Homer crosslinking proteins include reduced Shank3 and NR1
expression and increased ubiquitination in Homer triple KO,
Homer1 KO, and Homer2/3 KO brain. Moreover, Homer1a
expression, which inhibits the formation of Homer-Shank3
complex (Hayashi et al., 2009), mimics Homer KO to reduce
Shank3 expression, whereas selective genetic deletion of
Homer1a results in increased Shank3 and reduced ubiquitination
in brain. In extending this model to include the effect of Shank3
mutation, we note that Shank3DC protein is stably expressed
in the Shank3(+/DC) mice and physically associates with full-
length Shank3 from brain. Because Shank3DC lacks the
Homer-binding domain and associates with full-length Shank3,
its incorporation with WT Shank3 effectively reduces Homer
crosslinking of the Homer-Shank3 protein complex. Acute over-
expression of Shank3DC in neurons reduces WT Shank3,
providing evidence that downregulation of WT Shank3 is due
to Shank3DC expression. We do not detect ubiquitination of
Shank3DC even from Shank3(DC/DC) brain, which mitigates
the notion that Shank3DC is primarily ubiquitinated and ‘‘drags’’
the rest of the proteins along. This model predicts that any
mutation of Shank3 or Homer that effectively reduces the
stability of the Homer-Shank complex will lead to increased
ubiquitination and proteasomal degradation of Shank3 and
NR1. This could include deletions or point mutations of Shank3
RE
TR
A(C) mGluR-dependent chemical LTD induced by DHPG is enhanced in Shank3(+
(D) LTD produced by paired-pulse low-frequency stimulation is increased in the
stimulation. p < 0.05 (scale bars, 1 mV/10 ms).
(E) mGluR-LTD expressed in Shank3(+/DC) mice is completely blocked by prote
All quantitative data are shown as means ± SEM. All p values are derived from a
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or Homer. Consistent with this model, Homer1 KO mice exhibit
behavioral phenotypes (Szumlinski et al., 2005) similar to those
of Shank3(+/DC) mice.
Our model begs the question of why Shank3 expression and
ubiquitination should be sensitive to physical association with
Homer. We note that manipulations of Homer1a can influence
Shank3 expression and ubiquitination, and this reinforces the
notion that Shank3 is a nodal point for regulation of synaptic
function in response to natural activity. Homer1a expression is
tightly linked to behavioral experience (Brakeman et al., 1997)
and can also be induced by a variety of pharmacological and
pathological stimuli. Thus, dynamic expression of Homer1a
could contribute to the disassembly of Homer-Shank3 com-
plexes, especially if the complex is weakened by mutations of
Shank or Homer. By this mechanism, Homer1a expression could
contribute to the pathogenesis of ASD.
Our studies also suggest a link between Shank3 and group I
mGluR function. The molecular basis of enhanced mGluR-LTD
in Shank3(+/DC) does not appear to be linked to altered expres-
sion of mGluRs. mGluR-LTD is increased in Fmr1 KO mice and
this has been linked to neurological deficits in this mouse and
in patients with fragile X disease (Bear et al., 2004). Thus,
enhanced mGluR-LTD may contribute to behavioral deficits in
the Shank3(+/DC) mice.
Shank3(+/DC)mice exhibit behavioral phenotypes that parallel
symptoms of ASD. The most striking differences between
Shank3(+/DC) and WT mice were observed in a social recogni-
tion test that allowed for engagement in reciprocal interactions.
Shank3(+/DC) mice reacted to novel conspecifics by a sharp
increase in aggression rather than an increase in social investiga-
tion. Aggressive behaviors of Shank3(+/DC) mice were not
generalized across different tasks, indicating that the exagger-
ated aggression is likely a reaction to changes in social routine
rather than a result of their generalized aggressiveness. Infer-
ences regarding phenotypic relevance between mouse and
human behaviors, such as aggression in individuals with ASD
(Kanne and Mazurek, 2010), are difficult; however, the findings
of exaggerated aggressiveness to novel conspecifics as well
as deficits in ultrasound vocalization and alterations in social
approach behaviors indicate that the effects of Shank3(+/DC)
mutation are detected on multiple domains of social interactions
tested in a species-specific manner.
The decrease in NR1 observed in Shank3(+/DC) mice invites
comparisons with mice hypomorphic for NR1 (Mohn et al.,
1999). The preserved structure of synapses and spines that
are observed in Shank3(+/DC) mice is consistent with re-
ports from the conditional NR1 KO where NR1 excision within
CA1 did not affect spine density (Rampon et al., 2000). The
most striking difference between mice hypomorphic for NR1
and Shank3(+/DC) mice is that behavioral phenotypes of
Shank3(+/DC) mice occur in the context of normal cognitive
TE
D/DC) mice. p < 0.05 (scale bars, 1 mV/10 ms).
Shank3(+/DC) mice. The mean values were significantly different 30 min after
in synthesis inhibitor cycloheximide (CHX, 60 mM). Scale bars, 1 mV/10 ms.
Student’s t test. See also Figure S5.
Figure 6. Shank3(+/DC) Mice Display Aberrant Social Behaviors in Reciprocal and Indirect Social Interactions
(A) Duration of social investigation of a free-roaming stimulus mouse in consecutive trials of the habituation-dishabituation paradigm. Brackets indicate
a significant main effect of genotype (p < 0.05); asterisks show between-genotype differences at a particular trial (*p < 0.05 and **p < 0.01) (n = 20 per genotype).
(B) Social investigation as in (A) for subgroups of Shank3(+/DC) (n = 9) and WT (n = 8) that showed no aggressive behaviors during testing. Difference
nonsignificant.
(C) Social investigation as in (A) for subgroups of Shank3(+/DC) (n = 11) and WT (n = 12) that showed aggressive behaviors during testing.
(D) Duration of aggressive behaviors for the groups of mice shown in (C).
(E) Social investigation of an enclosed stimulus mouse in consecutive trials of the habituation-dishabituation paradigm. No significant differences were found
between Shank3(+/DC) (n = 12) and WT (n = 14). The same test mice were used for (E)–(L).
(F) Latency to the first aggression episode in a neutral arena and in a test mouse’s home cage.
(G and H) Duration of investigation of an enclosed male (G) or female (H) mouse and an inanimate empty enclosure.
(I and J) Dynamics of social investigation of an enclosedmale stimulusmouse in novel (I) and familiar environment (J). The 1st (I) and the 4th (J) repetitions of the test
are shown.
(K) Dynamics of social investigation of an enclosed female stimulus mouse in familiar environment. The test was conducted in the same environment as (I)–(J).
No between-genotype differences were observed.
(L) Latency of the first approach to an enclosed female measured during the test shown in (H) and (K). Shank3(+/DC) mice (n = 12) took significantly longer to
approach the social stimulus than WT (n = 14) (Student’s t test, p < 0.05).
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Figure 7. Shank3(+/DC) Mice Display Schizophrenia-Related Behavioral Phenotypes but Preserved Spatial and Fear Memories
(A) Amplitude of acoustic startle reaction as a function of stimulus intensity. Asterisks indicate that amplitudes of reactions to startle stimuli (110 or 120 dB) in
Shank3(+/DC) mice (n = 12) were significantly lower than in WT (n = 14) (p < 0.001). The stimuli used as prepulses (68 and 72 dB) did not evoke startle reactivity in
either of the genotypes.
(B) Raw means of prepulse inhibition uncorrected for differences in startle reactivity between Shank3(+/DC) and WT.
(C and (D) Scatterplots of the startle amplitude (x axis) and levels of prepulse inhibition (y axis) in trials with a 120 dB startle stimulus for WT (C) and Shank3(+/DC)
(D) mice. Thick and thin lines show linear regression lines fitted to the data from the trials with 4 or 8 dB prepulse, respectively. Pearson correlations between these
variables were significant for WT but not Shank3(+/DC) mice (see Table S3).
(E) Means of prepulse inhibition in WT and Shank3(+/DC) mice corrected by ANCOVA for significantly different levels of startle amplitude. Asterisk shows
a significant between-genotype difference (p < 0.01).
(F andG)Motor activation (F) and dose-response (G) toMK-801. Area under the curve (G) was calculated from (F) as a total motor activity 15min after an injection.
Asterisks show a significant between-genotype difference (p < 0.001). WT n = 8,8,8 and Shank3+/DC n = 6,8,8 for MK-801 doses 0, 0.2, and 0.3 mg/kg,
respectively.
(H and I) Motor activation (H) and dose-response (I) to amphetamine. Asterisk indicates a significant between-genotype difference (p < 0.05). WT n = 8,13,5 and
Shank3(+/DC) n = 6,11,6 for amphetamine doses 0, 2, and 3 mg/kg, respectively.
Error bars in (A)– (I) are means ± SEM. See also Figure S7 and Table S3.TR
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NMDAR-dependent LTP and LTD are reduced in Shank3(+/DC)
hippocampus but are not absent, and plasticity is apparently
sufficient for normal cognitive function. The preserved cognition
in these mice mitigates the concern that aberrant social behav-
iors might arise nonspecifically in a mouse with major cognitive
dysfunction and suggests that Shank3DC models will be useful
to explore the cellular and developmental determinants of social
deficits associated with ASD and to relate these to a molecular
model that includes enhanced ubiquitination of NR1. Our
studies, however, should not be taken as direct evidence of
a role of Shank3 in schizophrenia because human genetic
evidence remains incomplete. Genetic studies report linkage of
RE
(M) Latencies to the first ultrasound call emitted by Shank3(+/DC) mice (n = 11)
(n = 11) (Student’s t test, p < 0.05).
Brackets in (A) and (I)–(J) indicate a significant main effect of genotype (p < 0.05), a
(*p < 0.05 and **p < 0.01). Error bars in (A)– (M) are means ± SEM. See also Figu
770 Cell 145, 758–772, May 27, 2011 ª2011 Elsevier Inc.schizophrenia at the 22q11-13 locus, which includes Shank3
(Condra et al., 2007; DeLisi et al., 2002), but the single reported
association of Shank3 mutations with schizophrenia (Gauthier
et al., 2010) is notable for inclusion of patients with early onset
symptoms that may overlap with ASD (Rapoport et al., 2009).
Nevertheless, our study supports the notion that patients with
ASD or schizophrenia may share the molecular pathology of
reduced NMDAR function.EXPERIMENTAL PROCEDURES
Detailed experimental methods are provided in the Extended Experimental
Procedures.in the presence of a free-roaming female were significantly longer than in WT
nd asterisks in (A)–(M) show between-genotype differences at a particular trial
re S6, Table S2, and the Extended Experimental Procedures.
Animals
Mice were generated on a mixed 129s6; C57BL6/J background and back-
crossed to C57BL6/J background to at least the F5 generation. Littermate
pairs of male mice (unless otherwise noted) 3 to 6 months of age were used
in behavioral testing. All procedures involving animals were under the guide-
lines of JHU and UTSW Institutional Animal Care and Use Committee.
Behavioral Testing
Behaviors were recorded by computer-based tracking systems (HVS Image
Analysis VP-200, HVS Image, Hampton, England; Any Maze 4.72, Stoelting
Co, Wood Dale, IL; Noldus, Ethovision 2.3.19, SR-LAB, San-Diego Instru-
ments, CA, USA) and scored when necessary by trained observers blind to
genotype using a computer-assisted data acquisition system.
Measuring In Vivo Ubiquitination
The ubiquitination of Shank3 and NR1was measured from cortical lysates and
is described in detail in the Extended Experimental Procedures.
Electrophysiology
Electrophysiology was done using standard techniques. Details are provided
in the Extended Experimental Procedures.
Statistical Analyses
The behavioral data were analyzed using ANOVA/ANCOVA with the statistical
package STATISTICA 8.0 (StatSoft, Tulsa, OK, USA) and a minimal level of
significance p < 0.05. Fisher LSD post-hoc tests were applied to significant
main effects or interactions. All data are shown as means ± standard error of
the mean (SEM) unless noted otherwise. ASUPPLEMENTAL INFORMATIONSupplemental Information includes Extended Experimental Procedures, sevenfigures, and three tables and can be found with this article online at doi:10.
1016/j.cell.2011.03.052.
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